The CSL Ltd (ASX: CSL) share price is 2% higher at $145.71 a piece in Thursday morning trade. At the time of writing, the beaten-down biotech stock is down 15.24% year to date and 44.85% over the year.

It’s no secret that the CSL share price has taken a beating over the past six months. The biotech stock has been subdued since it crashed 15% following its half-year results and shock CEO exit in early February. 

And the drop is just one of many headwinds the company has faced over the past 6 months.

The company’s shares suffered a brutal sell-off in mid-August after its FY25 result and surprise restructure announcement. Two and a half months later, the share price dropped another 19.2% to a new low when it downgraded its FY26 revenue…